Anthera Pharmaceuticals (OTC:ANTH +8%) moves higher after saying that an abstract of the results from its Phase 2b clinical study examining the treatment effect of blisibimod in systemic lupus erythematosus patients has been accepted as a late-breaking poster presentation at the 2012 Annual Scientific Meeting of the American College of Rheumatology and the Association of Rheumatology Health Professionals.
Anthera Pharmaceuticals (OTC:ANTH +8%) moves higher after saying that an abstract of the results...
Recommended For You
More Trending News
About ANTH Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
ANTH | - | - |
Anthera Pharmaceuticals, Inc. |